,outcome,arm 1,arm 2
0,intervention,PF tafluprost and,PF timolol patients
0,ocular pain/stinging/irritation,"2.5, 4.4%",1.5%
0,"ocular pain/stinging/irritation, total study group",4.6%),4.6%)
